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Background: Autism spectrum disorder (ASD) is characterized by deficits in communication and social ability, as
well as restricted interests and repetitive behavior. Anxiety is a persistent anticipation or apprehension about one or
more situations to which a person is exposed, and affects many people, including children with ASD. Stress, by
contrast, is a response to situations that are threatening, uncontrollable, or unexpected. Indices of anxiety are often
measured through informants, with parents and teachers serving as the primary sources of reported anxiety in
children. However, self-report measures exist, allowing current (state) and persistent (trait) anxiety to be assessed.
The current study was designed to evaluate whether children with autism could identify their own levels of anxiety
and the degree to which these levels were associated with symptom profile and physiological arousal.
Methods: Self-reported state and trait anxiety were collected during exposure to different stress paradigms for 40
children (21 typically developing, 19 with autistic disorder) and compared to parent reported social ability (Social
Responsiveness Scale) and stress responsivity (cortisol).
Results: Significant differences were found between typically developing and children with autism for both state
and trait anxiety across all conditions. Associations were identified between severity of parent-reported social
impairment and both types of self-report anxiety. No relationship was found between stress (salivary cortisol)
and anxiety in children with autism.
Conclusions: Children with autism are able to consistently report their persistent level of anxiety symptoms in
stressful situations of benign character. Therefore, the inclusion of such measures may be useful in identifying
and tracking symptoms in children with autism under appropriate circumstances.
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In addition to the primary impairments in reciprocal social
communication and repetitive, restricted behaviors in
autism spectrum disorder [1], there are frequent reports
of comorbid anxiety disorders such as phobias, social
anxiety disorder, and obsessive-compulsive disorder [2].
Anxiety, defined here as a persistent anticipation or ap-
prehension regarding one or more situations to which a
person is exposed, is an acceptable and typical reaction
to some events. Clinical anxiety disorders, however, are* Correspondence: blythe.corbett@vanderbilt.edu
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distribution, and reproduction in any mediumcharacterized by excessive worry and distress [3], and are
among the most commonly reported childhood disorders
with rates ranging from 3% to 24% in the general popula-
tion [4]. High frequencies of anxiety are found in autism
as well, with reported rates of comorbid anxiety disorders
as high as 42% to 55% [5,6], and as many as 84% showing
some level of impairing anxiety [7-10]. The nature of the
link between anxiety symptoms and autism symptomology
is unclear, with some investigations showing a lack of
correspondence [11,12], while others show relations to spe-
cific symptoms such as hypersensitivity to sensory stimuli
[13]. Links with comorbid conditions such as disruptive
behavior have also been demonstrated [14]. Moreover,
beyond the diagnostic impairments of autism, parentsentral Ltd. This is an open access article distributed under the terms of the
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source of challenge they face [15].
Longitudinal and developmental neuroscience studies
reveal that alongside cognitive and neural development,
anxiety often follows a developmental trajectory starting
early in life and proceeding into adolescence and adult-
hood [16,17]. For example, in a study exploring error
related negativity, an event related potential component
shown to be more prominent in adult anxiety, Meyer
and colleagues [18] reported changes in anxiety as a func-
tion of age in children 8 to 13 years of age. In children
with autism, there is evidence that age is a significant
factor not only in the prevalence of anxiety but also the
type of anxiety present [2]. It is important to acknow-
ledge, however, that overall diagnostic stability of anxiety
over extended periods of time is, at best, moderate in
children and adolescents [19,20]. While these emerging
studies support consideration of cognitive development
when investigating anxiety there is a paucity of know-
ledge pertaining to intellectual functioning and its rela-
tionship to anxiety in children with neurodevelopmental
disorders such as autism. Based on recent findings there
appears to be a relationship between level of cognitive
function and anxiety; specifically, intellectually high func-
tioning children with autism are at particular risk for
anxiety disorders [21]. The need for accurate tools for
rapid and accurate assessment of anxiety in this popula-
tion is in many respects drawn from the necessity of iso-
lating these developmental, maturational, and cognitive
factors in respect to their contributions to pathological
anxiety.
Cognitive ability and impairment in autism are distinct;
thus, severity of impairment in other core domains, such
as social difficulty, can be major contributors to anxiety.
Additionally, while autism symptom expression and social
anxiety symptoms have been associated in early life,
including non-autistic children with clinical anxiety disor-
ders displaying autism-like symptoms and developmental
traits [22], the relationship as children age becomes more
complex and less understood. Children with autism and
higher anxiety display more overall repetitive behaviors,
while showing a specific positive relationship between
anxiety levels and desire for environmental consistency.
In contrast, children with autism and lower anxiety dis-
play a positive association between anxiety and sensory
motor repetitive behaviors [23]. There is also evidence
that severity of excessive anxiety is associated with de-
creased quality of life in children with autism, as well as
those with typical development [24].
Although a certain amount of anticipatory anxiety is
considered adaptive, it can become pathological when
the worry is excessive or uncontrollable and begins to
exert strong influences on behavior and cognition [3].
Increased arousal to perceived novel, uncontrollable, andunexpected or socially threatening situations can also be
adaptive [25,26] unless the response is frequent, intense,
or in response to a benign situation. In other words, both
the anticipation of potentially threatening events (anxiety)
as well as the response to such events (stress) can be
appropriate. Disorders marked by atypical perception
or response to environmental stimuli, such as ASD, may
therefore contribute to inappropriate and pathological
activation of arousal systems.
One of the primary stress systems, the hypothalamic-
pituitary-adrenocortical axis (HPA) responds consistently
to perceived novel or unfamiliar situations. Cortisol is a
glucocorticoid associated with activation of the HPA
axis and can serve as an important biomarker of stress
to a variety of different stimuli [27,28]. Previous research
has suggested that many children with autism exhibit
dysregulation of the HPA system evidenced by enhanced
responsivity in different social and non-social situations
[29-34]. Higher cortisol levels have been reported in chil-
dren with autism in response to non-social stimuli includ-
ing exposure to medical procedures such as phlebotomy
[34]. Social scenarios have also resulted in activation of
the HPA axis and subsequently elevated cortisol during
school integration [33], social interaction with peers on a
playground [30,35], and engagement with unfamiliar chil-
dren [32]. However, not all social stressors are salient for
youth with ASD, as a widely recognized social evaluative
stressor, the Trier Social Stress Test - Child Version
(TSST-C) [36], fails to provoke a stress response in par-
ticipants with autism [30,31,37,38]. In typically develop-
ing children, longitudinal cortisol measurements have
shown that persistence of anxiety disorders is associated
with increased diurnal cortisol levels, as well as a reduced
cortisol awakening response [39], indicating that excessive
long-term (trait) anxiety can contribute to increased physio-
logical stress. Despite this relationship, anxiety and stress
can sometimes be disassociated, particularly in conditions
involving acute (state) anxiety. It has been shown that
levels of anxiety and stress are frequently distinct in
children with and without autism [31,32]. This lack of a
direct biological corollary means that measuring anxiety
is often accomplished via proxy measures such as parent
report, to the exclusion of more direct self-report mea-
sures, as the reliability of the latter has been questioned.
Specifically, it has been argued that individuals with aut-
ism may not be able to reliably or accurately assess their
personal anxiety or affective states [40-42]. This has, in
part, been attributed to deficiencies in self-referential
cognition [43] as well as deficits in identifying cognitive
and emotional states frequently referred to as ‘theory of
mind’ [44,45]. Some examinations of informant agree-
ment between parents and their children with autism
have shown meaningful agreement [46,47] comparable
to typically developing youth [48,49]. However, others
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assertion of deficits in self-report ability in this popu-
lation [40-42].
It should be noted that, while self-reports have been
questioned, parent reports are also inconclusive. Recent
studies in adolescents with autism suggest discrepancies
across informants (parents versus self-reports) for social
functioning [50] and quality of life [51]. Importantly, in
regards to anxiety symptoms in youth with autism there
appears to be consistency across multiple informants
(parent, teacher and self-report) regarding the assess-
ment of psychiatric symptoms [52] as well as in response
to treatment [53]. These reports are comparable to stud-
ies of typically developing children that also show multi-
informant consistency [48]. While there have been few
studies considering the ability of children with autism to
self-report mood states, investigating the reliability and
stability of self-reported anxiety in the population is a
necessary step for future use of self-report measures.
As part of comprehensive studies examining biobe-
havioral profiles of children with autism parent report,
self-report, and physiological stress data were collected
during play with peers [35], exposure to a mock mag-
netic resonance imaging (MRI) scanner [54], and social
evaluation [31]. This repeated participation offered a unique
opportunity to investigate relationships between anxiety
and stress. Specifically, we examined: (1) the long-term
stability of self-reported state and trait anxiety in autism
over three stress paradigms; (2) the relationship of self-
reported anxiety to parent-reported functioning; and (3)
the association between reported anxiety and physio-
logical stress responses. Finally, the exposure to different
paradigms afforded the examination of differences based
on the social value of stressors, with the MRI serving as a
non-social stressor [55], the playground as a benign social
stressor [35], and the TSST-C [56] serving as a measure
of social evaluative threat. We sought to determine whether
the social or non-social nature of the administered
stressor influenced the relationship between self-reported
anxiety and the physiological stress response as measured
by salivary cortisol. We hypothesized that: (1) the children
with autism would show consistency in self-reported state
and trait anxiety across the paradigms; (2) self-report
anxiety would be negatively correlated with parent report
of social functioning such that higher levels of anxiety
would be associated with lower social functioning; and (3)
self-reported anxiety would be correlated with physio-
logical stress indicated by salivary cortisol levels.
Methods
Participants were recruited through distributed flyers and
direct phone contact from a subject tracking system for
a playground study examining HPA reactivity to social
stressors in children with autism. After completion ofthe initial playground paradigm participants were re-
cruited by phone for up to two additional studies investi-
gating reactivity to both social and non-social stressors.
Only a portion of the participants chose to return for
each of the additional studies. The two additional studies
had an average latency of 6 months from the initial play-
ground study, with a range of 4 to 9 months. Participants
provided saliva samples at 20-minute intervals for later
analysis examining salivary cortisol levels at each of the
three different stress paradigms described below. Add-
itionally, two separate self-report measures of anxiety
were completed at each study session by the participants,
while a parent-report measure of social ability was col-
lected at the initial playground session.
Participants
The playground study consisted of 40 healthy, age matched,
unmedicated, prepubertal, male children 8 to 12 years
of age. A total of 19 participants were diagnosed as
having autistic disorder, and 21 were typically developing.
Diagnosis was based on the Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV) cri-
teria [3] and established by all of the following: (1) a previ-
ous diagnosis by a psychologist, psychiatrist, or behavioral
pediatrician with autism expertise; (2) clinical judgment
and (3) corroborated by a total score on the social-
communication scale of the Autism Diagnostic Observa-
tion Schedule (ADOS) [57], administered by research-
reliable personnel, with a total score at or above the
autism threshold for Module 3. Diagnostic and IQ mea-
sures were completed together at a separate study visit
preceding playground participation. Race/ethnicity of par-
ticipants was reported by parents as follows: Caucasian
25 (62.5%), Hispanic 6 (15%), African-American 2 (5%),
Asian-American 2 (5%), and other 1 (2.5%). Four partic-
ipants (10%) had no reported race/ethnicity, or had no
available data.
A portion of the participants from the playground
sample, consisting of 15 (71%) of the typically develop-
ing children and 11 (58%) of the children with autism,
participated in an additional study using a mock MRI as
a non-social stressor. A second subset of the playground
sample, including 16 (76%) of the typically developing
children and 13 (68%) of the children with autism, par-
ticipated in the TSST-C, a social stress paradigm. Ten
(48%) of the typically developing children and five (26%)
of the children with autism from the original playground
sample participated in both the mock MRI and TSST-C.
Study visits were ordered as follows: playground first,
followed by MRI, and finally TSST-C. Additional demo-
graphic information is included in Table 1.
Informed written consent was obtained from parents
and verbal assent was obtained from research partici-
pants prior to inclusion in the study. Participants were
Table 1 Demographic information
Sample Variable Autism mean Autism SD Typical mean Typical SD F P value
Playground IQ 98.56 17.95 120.80 12.35 20.14 <0.001
Playground AGE 9.99 1.29 9.92 1.49 0.001 0.99
MRI IQ 101.92 15.35 122.07 13.101 13.55 0.001
MRI AGE 10.52 0.94 9.83 1.58 1.773 0.195
TSST-C IQ 92.92 12.71 123.25 10.97 45.80 <0.001
TSST-C AGE 9.78 1.12 9.55 1.48 0.280 0.653
TSST-C Trier Social Stress Test - Child Version.
Simon and Corbett Journal of Neurodevelopmental Disorders 2013, 5:32 Page 4 of 10
http://www.jneurodevdisorders.com/content/5/1/32told they would be playing on a playground with peers
for the playground paradigm or that they would be
participating in a school-like performance task in the
TSST-C paradigm [56]. Participants in the mock MRI
condition were informed that they would be ‘practicing’
MRI procedures in a mock scanner. The University Insti-
tutional Review Board approved the study, which was
conducted in compliance with the Code of the Ethical
Principles for Medical Research Involving Human Sub-
jects of the World Medical Association (Declaration of
Helsinki).
Diagnostic and neuropsychological methods
The Autism Diagnostic Observation Schedule (ADOS; [58])
is a semistructured interview designed to assess behav-
iors indicative of autism. The ADOS was administered
by an independent and research reliable psychologist,
and has been validated in autistic populations.
The Wechsler Abbreviated Scale of Intelligence (WASI;
[59]) is a measure of cognitive ability that was used to
obtain a quick and reasonable estimate of a child’s intel-
lectual functioning. An estimated IQ ≥70 was required
for participation in the study. The WASI is validated for
typically developing individuals.
The Social Responsiveness Scale (SRS; [60]) is a 65-item
questionnaire completed by care providers to quantita-
tively assess the burden of autistic traits in their child. It
provides a total score as well as five treatment scales
(Social Awareness, Social Cognition, Social Communica-
tion, Social Motivation, and Autistic Mannerisms). The
SRS has been used in several behavioral and pharmaceut-
ical treatment studies in autism for example [61,62], and
has been validated in both typically developing children
and children with autism, with Cronbach’s α ranging
from 0.71 to 0.89. The total raw scores were used in the
analysis.
The State Trait Anxiety Inventory for Children (STAIC;
[63]) is a 40-item self-report form used to assess current
(state) as well as long-term and persistent (trait) anxiety
in children. It has been used extensively as a method of
collecting self-report anxiety data in children and yieldscomparable results to other self-report and parent-
report anxiety measures [64]. The measure has been vali-
dated in typically developing individuals with a Cronbach’s
α of 0.91. Raw scores for each type of anxiety were used in
the analysis.
The Multidimensional Anxiety Scale for Children (MASC;
[65]) is a 39-item anxiety self-report across clinically sig-
nificant symptom domains designed for use in children
ages 8 to 19. The MASC has been validated in typically
developing children, with a Cronbach’s α of 0.90 for the
full measure, 0.82 for the social anxiety subscale, and
0.66 for the coping subscale. The complete form was
used to gather information across all subscales for all
participants.
Playground paradigm
The playground social stress protocol was the positive
social stressor in this study. Participants were asked to
play on an enclosed 18.2 × 18.2 m playground with two
other age and gender matched children. The 20-minute
play period was subdivided into periods of prescribed
free and cooperative play was facilitated by a confederate
child on the playground communicating with the research
staff via concealed audio technology [30]. A total of four
salivary samples were obtained, including (PS1) a sample
taken 15 minutes after arrival, immediately prior to the
playground peer interaction, (PS2) immediately post play,
(PS3) 20-minutes post play, and (PS4) 40-minutes post
play (see Figure 1).
Mock MRI paradigm
The mock MRI is a non-social neutral stressor designed
to evaluate reactivity to a situation with significant sensory
components, including simulated MRI machine noises
and relative confinement inside the scanning bore [55].
Participants were then scanned in a real MRI machine
as part of a separate study protocol. A total of four salivary
samples were taken, (MS1) approximately 15 minutes
after arrival at the imaging facility just before exposure
to the mock MRI, (MS2) 20 minutes after the start of
the mock, (MS3) 40 minutes after the start of the mock,
Figure 1 Timeline for saliva sampling across the different stressors.
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(see Figure 1).TSST-C paradigm
The TSST-C is a well validated negative social stressor
in which participants are asked to make a public presen-
tation to neutral raters. The Trier Social Stress Test [56]
was originally developed for adults and later adapted to
children. In the child version, participants have 5 minutes
of preparatory time and then finish a story prompt for
5 minutes in front of an audience composed of two adult
raters. They are told that their presentation will be com-
pared to those of all the other participants. After the
5-minute presentation, participants are asked to serially
subtract a number determined by the child’s age and ability
level. Four saliva samples were collected, including (TS1)
10 minutes after arrival, immediately before the TSST-C,
(TS2) on completion of the TSST-C, (TS3) 20 minutes
after completion of the TSST-C, and (TS4) 40 minutes
after completion of the TSST-C (see Figure 1). Additional
samples were collected as part of the TSST-C protocol
[31], but were not part of the current investigation.STAIC and MASC administration
All three studies included a saliva sample taken after
exposure to the stressor. The STAIC and MASC were
administered to participants during the rest period im-
mediately following this sample. Parents were present
during administration of the STAIC and MASC, but were
not permitted to assist their child. Research personnel
carefully avoided referencing other terms used on the
measures when answering participant questions. For
example, the word nervous was avoided when describ-
ing what jittery means, as nervous appears later in the
measure. The use of multiple measures with each par-
ticipant allowed for better characterization of anxiety
along multiple axes; the MASC focusing on anxiety sub-
types, while the STAIC explored temporal characteristics.Cortisol sampling protocol
Established salivary collection protocols were carefully
followed, including using consistent collection materials
and methods, controlling the intake and time of drinks,
food, and prescription medications, as well as using
standardized procedures [54,66]. The basic procedure
involved giving the participant Trident® Original Sugarless
chewing gum to act as a salivary stimulant. The child then
emitted saliva into a collection tube via passive drool until
a total of 1 mL had been collected. Samples were stored
in a −20°C freezer and prior to assay were thawed and
centrifuged at 6,000 rpm for 10 minutes to separate the
aqueous component from mucins and other suspended
particles. Assays were performed using coated-tube radio-
immunoassay kits (Siemens Medical Solutions Diagnos-
tics, Los Angeles, CA, USA).
Statistical analysis
Between-group analyses for the autism and typically
developing groups were performed across demographic
(age and IQ) and dependent variables of interest (STAIC
and MASC anxiety) using independent two-sample t tests
if the assumption of normality held true; otherwise, the
equivalent non-parametric test was used. Pearson product
correlations were performed to assess the association
between self-reported anxiety and parent-reported social
functioning (SRS) and physiological levels (cortisol values),
respectively. Statistics were analyzed using SPSS version
21 (SPSS, Chicago, IL, USA).
Results
The primary aims of the study were to examine: (1) the
longitudinal consistency of self-reported state and trait
anxiety measures used with children with autism; (2) the
relationship between both types of self-reported anxiety
to parent-reported functioning; and (3) the association
between reported anxiety and physiological stress responses.
Self-reported anxiety was investigated across the two
groups revealing significant differences between the typic-
ally developing and autism groups in terms of trait anxiety
measured by the STAIC (see Table 2), with the autism
group reporting significantly higher levels of trait anxiety
in the playground and mock MRI conditions. In regards
to the evaluation of long-term stability of self-reported
anxiety, participants with autism demonstrated consistency
in their reported anxiety between the playground and MRI
conditions for both state (r = 0.685, P = 0.020) and trait
(r = 0.607, P = 0.048) anxiety (see Figure 2). The play-
ground and TSST-C anxiety reports, however, did not
share this relationship (P >0.05). Typically developing
children showed very strong consistency between the
playground and MRI for both state (r = 0.931, P <0.001)
and trait (r = 0.776, P = 0.001) anxiety. Trait anxiety
between playground and the TSST-C was also highly
Table 2 Anxiety measures (IQ controlled)
Measure Autism N Autism mean Autism SD Typical N Typical mean Typical SD F P value Eta2 Power
Playground state 19 30.79 6.99 21 26.52 5.13 0.55 0.46 0.114 0.579
Playground trait 19 38.95 8.55 21 30.29 4.74 15.43 <0.001 0.298 0.974
Mock MRI state 11 28.50 7.00 15 26.94 6.04 0.16 0.69 0.015 0.094
Mock MRI trait 11 37.50 8.92 15 28.31 6.72 6.55 0.017 0.272 0.850
TSST-C state 13 32.00 351 16 31.06 4.80 0.259 0.615 0.013 0.088
TSST-C trait 13 38.77 4.94 16 32.13 5.61 2.02 0.17 0.293 0.897
MASC total 19 59.61 13.76 21 47.86 8.59 6.80 0.01 0.223 0.895
MASC Multidimensional Anxiety Scale for Children, TSST-C Trier Social Stress Test - Child Version.
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and TSST-C reported anxiety were not made due to
limited sample size of participants shared between the
two conditions. Thus, the STAIC appears to be a stable
measure for use in children with autism in some stress
conditions (Figure 2).
Self-rated anxiety on the MASC was also found to be
significantly different between typically developing chil-
dren and those with autism (See Table 2). Comparisons
were also made between self-report state and trait anxiety
using the STAIC and the MASC self-report anxiety scales.
For the playground condition, overall state anxiety was
moderately related to the MASC social anxiety subscale
(r = 0.376, P = 0.026), while trait anxiety was strongly re-
lated to the same subscale (r = 0.716, P <0.001). There
were also relationships between the coping subscaleFigure 2 Association between playground and MRI trait anxiety
in children with autism and children with typical development.and both state (r = 0.335, P = 0.046) and trait (r = 0.396,
P = 0.017) anxiety in the playground paradigm. Add-
itionally, strong correlations were observed between the
MASC social anxiety subscale and trait anxiety at both
the MRI (r = 0.524, P = 0.006) and the TSST-C (r = 0.628,
P = 0.012).
An additional relationship was found between anxiety
in the playground condition and overall social function-
ing level measured by total score on the parent SRS
measure for both state (r = 0.453, P = 0.004) as well as
trait (r = 0.399, P = 0.012) anxiety. These results suggest
that children with lower levels of overall social ability
experience heightened anxiety in various situations when
compared to their higher functioning peers. Similarly, the
SRS Total Score was also correlated with MRI trait anxiety
(r = 0.495, P = 0.009) and TSST-C trait anxiety (r = 0.549,
P= 0.002). This demonstrates a relationship between parent-
reported social functioning and child self-reported anxiety
across conditions.
In regards to salivary cortisol levels, children with
autism showed significantly higher activation in response
to the playground social stressor (previously reported in
[35]), and to the mock MRI (F(1, 27) 5.106, P = 0.03) when
compared to typically developing children. In the TSST-C,
however, children with autism showed a lack of respon-
sivity compared to their typical peers, as previously
reported [31]. Correlational analyses using Pearson prod-
uct indicated a lack of association between cortisol levels
at any given time point and self-reported anxiety (all
P >0.05). Within group comparisons between the equiva-
lent saliva samples and self-report anxiety showed that
in children with autism there was no correlation between
cortisol and anxiety on any of the stressors. Typically
developing children, however, did show some relation-
ship between cortisol and anxiety at certain time points.
For example, salivary cortisol at arrival in children par-
ticipating in the MRI condition correlated with trait
anxiety (S1, r = 0.507, P = 0.045), whereas in the TSST-C
condition arrival cortisol correlated with state anxiety
(S1, r = 0.668, P = 0.006, and S2, r = 0.661, P = 0.007).
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The current investigation explored the long-term stability
of self-reported anxiety in autism as well as associations
to parent-reported functioning and physiological stress
responses. The findings reveal large differences between
the typically developing and autism groups in trait anx-
iety and MASC subscales, providing further support
that anxiety is a significant and common condition in
children with autism (see, for example, [5-10]). The
relative stability of self-report anxiety between the play-
ground and mock MRI conditions indicates that chil-
dren in this age group are potentially able to consistently
report their persistent (trait) anxiety in stressful situations.
Including basic self-report questionnaires, such as the
aforementioned measures, under novel or changing sit-
uations may help to identify children who are routinely
worried or anxious.
The lack of correspondence with the TSST-C reported
anxiety may be due, in part, to differences in stress re-
sponse, as the TSST-C failed to evoke a physiological
response in children with autism [31,67]. As more fully
described [30,31], children with ASD generally do not
perceive the TSST-C to be stressful. In order to trigger
the neuroendocrine cascade resulting in a release of
cortisol, a situation must be perceived as stressful [25,26].
Children with ASD may interpret the social evaluative
paradigm as being simply a cognitive exercise and thereby
not respond in a typical manner. Alternatively, due to
diminished social motivation [68], children with ASD
may be less provoked by the evaluative nature of the
task thereby contributing to a lower cortisol response
and diminished endorsement of anxiety.
Moreover, the physiological stress under which a child
with autism is requested to rate their general anxiety may
influence their response. In other words, under conditions
in which they exhibit physiological arousal as demon-
strated by cortisol elevation they may be better able to
rate their trait anxiety as being elevated, while under
conditions in which they do not demonstrate physio-
logical arousal such as the TSST-C, children with autism
may appraise their overall anxiety as being lower. Inter-
estingly, the children with autism did not consistently
endorse state or current anxiety during the time of the
stressor. It may be that children with autism are unable
to discern current states of functioning yet are able to
endorse enduring states of being. Sensory sensitivity
frequently found in individuals with autism may be
interfering with their ability to assess themselves cogni-
tively during an experience. In other words, their sensory
reactivity may be paramount and prevent them from being
able to adequately identify internal states. Since this is
merely conjecture, additional research is needed in this
area. Our hypothesis that self-reported anxiety would be
consistent across the different study paradigms wastherefore only partially correct as consistency was only
displayed for trait anxiety and only when the paradigm
provoked a stress response.
External social cues related to autism symptoms, as
well as direct cognitive awareness of one’s own impair-
ments are both potential sources of anxiety for individ-
uals with autism. Specific autism traits such as insistence
on sameness [69] and restricted interests [70] have also
previously been shown to relate directly to anxiety. The
correspondence between parent-reported functioning
and child anxiety levels reinforces the notion that a rela-
tionship exists between autism symptoms and anxiety
[13]. Interventions targeting anxiety have demonstrated
improvements in autism symptoms [71], indicating that
this relationship may be reciprocal. It is thus important
to consider children’s level of social function when
evaluating for symptoms of anxiety in this population. In
addition to core autism symptoms, anxiety also serves as
a major source of challenge for parents [15], thereby
warranting assessment and recommendations to assist
families with coping in situations that contribute to ex-
cessive worry, avoidance, or discomfort. As cognitive
ability and anxiety have a complex relationship, this
finding is restricted to individuals with normal cognitive
ability in addition to autism, and future investigations in
populations with a broader range of functioning are
needed. Our hypothesis that parent report of lower so-
cial ability would be associated with higher self-reported
anxiety is thus supported, but only within this higher
functioning cohort.
Our final hypothesis, that physiological stress measures
would be associated with self-report anxiety, proved incor-
rect, as the data showed no such relationship. Anxiety and
physiological stress, while often deeply intertwined, are
distinct constructs that may be individually provoked
under specific circumstances. The lack of correlation
between salivary cortisol and self-report anxiety across
all three stressors provides support for the distinctive-
ness of these constructs in children with autism [31]. In
typically developing children, a positive correlation was
present between reported anxiety and cortisol during
arrival (prior to the stressor) for both the MRI and
TSST-C conditions. Initial arrival for a novel activity can
easily provoke both feelings of anxiety as well as physio-
logical arousal. Additionally, the reduced consistency
between cognitive appraisal and physiological response
noted above may be a result of the HPA dysfunction
commonly found in children with autism [72].
These findings demonstrate that children with average
cognitive ability in addition to autism may be able to ac-
curately assess their personal anxiety levels in contrast
to some reports that question the usefulness of such
measures [41,42], or show altered affective report [40].
These results build on evidence that adolescents with
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cluding anxiety [52]. While it remains to be seen in chil-
dren with autism, under some conditions adolescents with
the disorder may be more accurate reporters regarding
their own mood dysregulation than their parents [52].
Taken together, these studies support the use of multi-
informant measures to gain an enhanced understanding
of perceived internal state (self-report), behavioral presen-
tation (parent and teacher report) and symptom profile
(clinical assessment) in individuals with autism. Addition-
ally, informant discrepancies that arise in the process may
offer valuable, clinically-relevant information in addition
to that provided by self-report or parent report alone [50].
Additionally, the present study indicates that social func-
tioning level is a prime indicator for the anxiety levels of
children with autism.
Clinical implications of this study include providing
evidence of long-term stability of the trait portion of the
STAIC in this population across consistent conditions.
Support is also present for using parent-reported func-
tioning measures, such as the SRS, as an alternate method
of assessing anxiety risk. As the STAIC and MASC are
normalized for typically developing individuals, closer
inspections through reliability and validity studies, which
have been conducted in typically developing youth [73],
are needed for individuals with autism.
Conclusions
Due to the frequency of occurrence and deleterious effects
on quality of life, addressing anxiety in children with aut-
ism is highly important. Interventions to reduce anxiety
are often warranted and may be especially prudent in
populations with lower social functioning, particularly
those with self-assessed anxiety relating to social inter-
action or coping ability. Cognitive behavioral therapy
(CBT) has been shown to be effective in children with
autism to ameliorate anxiety symptoms [71,74,75], and
autism specific anxiety interventions are under develop-
ment [76]. Use of STAIC trait anxiety provides an easily
administered indicator of whether CBT or other inter-
vention methods for anxiety are appropriate for a given
child. Self-report measures in adolescents with autism
and anxiety have corroborated treatment gains observed
by others following CBT [53] suggesting that children
may similarly be able to identify changes over time in
their perceived trait anxiety.
Additionally, the current results demonstrate the lack
of an association between stress, as measured by salivary
cortisol, and self-reported anxiety in children with autism.
While this has previously been established in regards to
the TSST-C, this study extends the finding to stressors
that induce physiological reactivity in children with
autism. This is an important consideration for research
involving biological stress measurements as it stronglyindicates that anxiety cannot be used as a predictor of
biological reactivity to the environment in autism. Some
evidence exists of a relationship in typically developing
children between salivary cortisol at arrival and self-
report anxiety, and future research would be well guided
to examine this further.
Despite these interesting findings, there are some limi-
tations to acknowledge. The sample size was somewhat
moderate for a few of the experimental conditions. Fur-
thermore, the age range was narrow due to the develop-
mental play paradigm and exclusion criteria for puberty.
While diagnostic and study inclusion criteria in the field
have changed [1], the children in the sample were diag-
nosed, according to DSM-IV criteria, as having strictly
defined autistic disorder [3]. Generalizability of the study
is thus limited to male children with relatively unimpaired
cognitive ability within a rather narrow age range. An
additional factor limiting generalizability of this study
was the lack of socioeconomic status data available for
participants. Nevertheless, we view the rigorous clinical
characterization of our participants as a strength of the
study. Finally, because the nature of the study is largely
exploratory, we acknowledge that the possibility of type 1
error is elevated due to the number of analyses conducted.
In summary, many children with autism exhibit per-
sistent anxiety that can be captured via self-report mea-
sures. Furthermore, children’s anxiety is directly related
to their level of social impairment. While no relationship
was found between salivary cortisol reactivity and self-
report anxiety, it appears that reported anxiety remains
consistent between conditions that evoke similar physio-
logical responses. Future research designed to identify
children with enduring and impairing anxiety remains
an important pursuit. Associations with social, percep-
tual, and cognitive functioning may identify subgroups at
risk and in need of targeted treatment for anxiety in autism.
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